Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Oct;35(10):1947–1952. doi: 10.1128/aac.35.10.1947

Antibiotic tissue penetration and its relevance: models of tissue penetration and their meaning.

D E Nix 1, S D Goodwin 1, C A Peloquin 1, D L Rotella 1, J J Schentag 1
PMCID: PMC245306  PMID: 1759812

Full text

PDF
1947

Images in this article

1949Image
on p.1949
1950Image
on p.1950

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barza M., Cuchural G. General principles of antibiotic tissue penetration. J Antimicrob Chemother. 1985 Jan;15 (Suppl A):59–75. doi: 10.1093/jac/15.suppl_a.59. [DOI] [PubMed] [Google Scholar]
  2. Barza M., Samuelson T., Weinstein L. Penetration of antibiotics into fibrin loci in vivo. II. Comparison of nine antibiotics: effect of dose and degree of protein binding. J Infect Dis. 1974 Jan;129(1):66–72. doi: 10.1093/infdis/129.1.66. [DOI] [PubMed] [Google Scholar]
  3. Barza M., Weinstein L. Penetration of antibiotics into fibrin loci in vivo. I. Comparison of penetration of ampicillin into fibrin clots, abscesses, and "interstitial fluid". J Infect Dis. 1974 Jan;129(1):59–65. doi: 10.1093/infdis/129.1.59. [DOI] [PubMed] [Google Scholar]
  4. Bergan T. Pharmacokinetics of tissue penetration of antibiotics. Rev Infect Dis. 1981 Jan-Feb;3(1):45–66. doi: 10.1093/clinids/3.1.45. [DOI] [PubMed] [Google Scholar]
  5. Bonati M., Kanto J., Tognoni G. Clinical pharmacokinetics of cerebrospinal fluid. Clin Pharmacokinet. 1982 Jul-Aug;7(4):312–335. doi: 10.2165/00003088-198207040-00003. [DOI] [PubMed] [Google Scholar]
  6. Cars O., Ogren S. Antibiotic tissue concentrations: methodological aspects and interpretation of results. Scand J Infect Dis Suppl. 1985;44:7–15. [PubMed] [Google Scholar]
  7. Chisholm G. D., Waterworth P. M., Calnan J. S., Garrod L. P. Concentration of antibacterial agents in interstitial tissue fluid. Br Med J. 1973 Mar 10;1(5853):569–573. doi: 10.1136/bmj.1.5853.569. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Costerton J. W., Geesey G. G., Cheng K. J. How bacteria stick. Sci Am. 1978 Jan;238(1):86–95. doi: 10.1038/scientificamerican0178-86. [DOI] [PubMed] [Google Scholar]
  9. Drusano G. L. Role of pharmacokinetics in the outcome of infections. Antimicrob Agents Chemother. 1988 Mar;32(3):289–297. doi: 10.1128/aac.32.3.289. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Drusano G. L., Ryan P. A., Standiford H. C., Moody M. R., Schimpff S. C. Integration of selected pharmacologic and microbiologic properties of three new beta-lactam antibiotics: a hypothesis for rational comparison. Rev Infect Dis. 1984 May-Jun;6(3):357–363. doi: 10.1093/clinids/6.3.357. [DOI] [PubMed] [Google Scholar]
  11. EAGLE H., FLEISCHMAN R., MUSSELMAN A. D. The effective concentrations of penicillin in vitro and in vivo for streptococci, pneumococci, and Treponema pallidum. J Bacteriol. 1950 May;59(5):625–643. doi: 10.1128/jb.59.5.625-643.1950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Fabre J., Rudhardt M., Blanchard P., Regamey C. Persistence of sisomicin and gentamicin in renal cortex and medulla compared with other organs and serum of rats. Kidney Int. 1976 Dec;10(6):444–449. doi: 10.1038/ki.1976.131. [DOI] [PubMed] [Google Scholar]
  13. Fleishaker J. C., McNamara P. J. Performance of a diffusional clearance model for beta-lactam antimicrobial agents as influenced by extravascular protein binding and interstitial fluid kinetics. Antimicrob Agents Chemother. 1985 Sep;28(3):369–374. doi: 10.1128/aac.28.3.369. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Forsgren A., Bellahsène A. Antibiotic accumulation in human polymorphonuclear leucocytes and lymphocytes. Scand J Infect Dis Suppl. 1985;44:16–23. [PubMed] [Google Scholar]
  15. Gengo F. M., Schentag J. J. Methicillin distribution in serum and extravascular fluid and its relevance to normal and damaged heart valves. Antimicrob Agents Chemother. 1981 May;19(5):836–841. doi: 10.1128/aac.19.5.836. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Gengo F. M., Schentag J. J. Rate of methicillin penetration into normal heart valve and experimental endocarditis lesions. Antimicrob Agents Chemother. 1982 Mar;21(3):456–459. doi: 10.1128/aac.21.3.456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Gerding D. N., Hall W. H., Schierl E. A., Manion R. E. Cephalosporin and aminoglycoside concentrations in peritoneal capsular fluid in rabbits. Antimicrob Agents Chemother. 1976 Dec;10(6):902–911. doi: 10.1128/aac.10.6.902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Glauser M. P., Lyons J. M., Braude A. I. Prevention of pyelonephritis due to Escherichia coli in rats with gentamicin stored in kidney tissue. J Infect Dis. 1979 Feb;139(2):172–177. doi: 10.1093/infdis/139.2.172. [DOI] [PubMed] [Google Scholar]
  19. Hand W. L., King-Thompson N. L. Contrasts between phagocyte antibiotic uptake and subsequent intracellular bactericidal activity. Antimicrob Agents Chemother. 1986 Jan;29(1):135–140. doi: 10.1128/aac.29.1.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hoffstedt B., Walder M. Influence of serum protein binding and mode of administration on penetration of five cephalosporins into subcutaneous tissue fluid in humans. Antimicrob Agents Chemother. 1981 Dec;20(6):783–786. doi: 10.1128/aac.20.6.783. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Horwitz M. A., Silverstein S. C. Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes. J Clin Invest. 1980 Sep;66(3):441–450. doi: 10.1172/JCI109874. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Jacobs R. F., Wilson C. B. Intracellular penetration and antimicrobial activity of antibiotics. J Antimicrob Chemother. 1983 Oct;12 (Suppl 100):13–20. doi: 10.1093/jac/12.suppl_c.13. [DOI] [PubMed] [Google Scholar]
  23. Kornguth M. L., Kunin C. M. Uptake of antibiotics by human erythrocytes. J Infect Dis. 1976 Feb;133(2):175–184. doi: 10.1093/infdis/133.2.175. [DOI] [PubMed] [Google Scholar]
  24. Kunin C. M. Dosage schedules of antimicrobial agents: a historical review. Rev Infect Dis. 1981 Jan-Feb;3(1):4–11. doi: 10.1093/clinids/3.1.4. [DOI] [PubMed] [Google Scholar]
  25. Levy J., Smith A. L., Kenny M. A., Ramsey B., Schoenknecht F. D. Bioactivity of gentamicin in purulent sputum from patients with cystic fibrosis or bronchiectasis: comparison with activity in serum. J Infect Dis. 1983 Dec;148(6):1069–1076. doi: 10.1093/infdis/148.6.1069. [DOI] [PubMed] [Google Scholar]
  26. Lunke R. J., Fitzgerald R. H., Jr, Washington J. A., 2nd Pharmacokinetics of cefamandole in osseous tissue. Antimicrob Agents Chemother. 1981 May;19(5):851–858. doi: 10.1128/aac.19.5.851. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Mandell G. L. Interaction of intraleukocytic bacteria and antibiotics. J Clin Invest. 1973 Jul;52(7):1673–1679. doi: 10.1172/JCI107348. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Mandell G. L., Vest T. K. Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies. J Infect Dis. 1972 May;125(5):486–490. doi: 10.1093/infdis/125.5.486. [DOI] [PubMed] [Google Scholar]
  29. Minuth J. N., Musher D. M., Thorsteinsson S. B. Inhibition of the antibacterial activity of gentamicin by urine. J Infect Dis. 1976 Jan;133(1):14–21. doi: 10.1093/infdis/133.1.14. [DOI] [PubMed] [Google Scholar]
  30. Neu H. C. Current practices in antimicrobial dosing. Rev Infect Dis. 1981 Jan-Feb;3(1):12–18. doi: 10.1093/clinids/3.1.12. [DOI] [PubMed] [Google Scholar]
  31. Nix D. E., Goodwin S. D., Peloquin C. A., Rotella D. L., Schentag J. J. Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response. Antimicrob Agents Chemother. 1991 Oct;35(10):1953–1959. doi: 10.1128/aac.35.10.1953. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Norrby R. A review of the penetration of antibiotics into CSF and its clinical significance. Scand J Infect Dis Suppl. 1978;(14):296–309. [PubMed] [Google Scholar]
  33. Prokesch R. C., Hand W. L. Antibiotic entry into human polymorphonuclear leukocytes. Antimicrob Agents Chemother. 1982 Mar;21(3):373–380. doi: 10.1128/aac.21.3.373. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Rolinson G. N. The significance of protein binding of antibiotics in antibacterial chemotherapy. J Antimicrob Chemother. 1980 May;6(3):311–317. doi: 10.1093/jac/6.3.311. [DOI] [PubMed] [Google Scholar]
  35. Rolinson G. N. Tissue penetration of antibiotics. J Antimicrob Chemother. 1984 Jun;13(6):593–602. doi: 10.1093/jac/13.6.593. [DOI] [PubMed] [Google Scholar]
  36. Ryan D. M., Cars O. A problem in the interpretation of beta-lactam antibiotic levels in tissues. J Antimicrob Chemother. 1983 Sep;12(3):281–284. doi: 10.1093/jac/12.3.281. [DOI] [PubMed] [Google Scholar]
  37. Ryan D. M., Cars O. Antibiotic assays in muscle: are conventional tissue levels misleading as indicator of the antibacterial activity? Scand J Infect Dis. 1980;12(4):307–309. doi: 10.3109/inf.1980.12.issue-4.12. [DOI] [PubMed] [Google Scholar]
  38. Ryan D. M., Cars O., Hoffstedt B. The use of antibiotic serum levels to predict concentrations in tissues. Scand J Infect Dis. 1986;18(5):381–388. doi: 10.3109/00365548609032352. [DOI] [PubMed] [Google Scholar]
  39. Ryan D. M., Hodges B., Spencer G. R., Harding S. M. Simultaneous comparison of three methods for assessing ceftazidime penetration into extravascular fluid. Antimicrob Agents Chemother. 1982 Dec;22(6):995–998. doi: 10.1128/aac.22.6.995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Schentag J. J., Cumbo T. J., Jusko W. J., Plaut M. E. Gentamicin tissue accumulation and nephrotoxic reactions. JAMA. 1978 Nov 3;240(19):2067–2069. [PubMed] [Google Scholar]
  41. Schentag J. J., Gengo F. M. Principles of antibiotic tissue penetration and guidelines for pharmacokinetic analysis. Med Clin North Am. 1982 Jan;66(1):39–49. doi: 10.1016/s0025-7125(16)31440-7. [DOI] [PubMed] [Google Scholar]
  42. Schentag J. J., Jusko W. J., Plaut M. E., Cumbo T. J., Vance J. W., Abrutyn E. Tissue persistence of gentamicin in man. JAMA. 1977 Jul 25;238(4):327–329. [PubMed] [Google Scholar]
  43. Schentag J. J., Jusko W. J., Vance J. W., Cumbo T. J., Abrutyn E., DeLattre M., Gerbracht L. M. Gentamicin disposition and tissue accumulation on multiple dosing. J Pharmacokinet Biopharm. 1977 Dec;5(6):559–577. doi: 10.1007/BF01059684. [DOI] [PubMed] [Google Scholar]
  44. Schentag J. J., Lasezkay G., Cumbo T. J., Plaut M. E., Jusko W. J. Accumulation pharmacokinetics of tobramycin. Antimicrob Agents Chemother. 1978 Apr;13(4):649–656. doi: 10.1128/aac.13.4.649. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Schentag J. J., Swanson D. J., Smith I. L. Dual individualization: antibiotic dosage calculation from the integration of in-vitro pharmacodynamics and in-vivo pharmacokinetics. J Antimicrob Chemother. 1985 Jan;15 (Suppl A):47–57. doi: 10.1093/jac/15.suppl_a.47. [DOI] [PubMed] [Google Scholar]
  46. Tsuji A., Terasaki T., Imaeda N., Nishide K., Nakashima E. Effect of extracellular water volume on the distribution kinetics of beta-lactam antibiotics as a function of age. J Pharmacobiodyn. 1985 Mar;8(3):167–174. doi: 10.1248/bpb1978.8.167. [DOI] [PubMed] [Google Scholar]
  47. Tune B. M., Kuo C. H., Hook J. B., Hsu C. Y., Fravert D. Effects of piperonyl butoxide on cephalosporin nephrotoxicity in the rabbit. An effect on cephaloridine transport. J Pharmacol Exp Ther. 1983 Mar;224(3):520–524. [PubMed] [Google Scholar]
  48. Van Etta L. L., Peterson L. R., Fasching C. E., Gerding D. N. Effect of the ratio of surface area to volume on the penetration of antibiotics in to extravascular spaces in an in vitro model. J Infect Dis. 1982 Sep;146(3):423–428. doi: 10.1093/infdis/146.3.423. [DOI] [PubMed] [Google Scholar]
  49. Van der Auwera P., Petrikkos G., Matsumoto T., Husson M. Influence of LY146032 on human polymorphonuclear leucocytes in vitro. J Antimicrob Chemother. 1988 Jan;21(1):57–63. doi: 10.1093/jac/21.1.57. [DOI] [PubMed] [Google Scholar]
  50. Vaudaux P., Waldvogel F. A. Gentamicin inactivation in purulent exudates: role of cell lysis. J Infect Dis. 1980 Oct;142(4):586–593. doi: 10.1093/infdis/142.4.586. [DOI] [PubMed] [Google Scholar]
  51. Verklin R. M., Jr, Mandell G. L. Alteration of effectiveness of antibiotics by anaerobiosis. J Lab Clin Med. 1977 Jan;89(1):65–71. [PubMed] [Google Scholar]
  52. Waterman N. G., Raff M. J., Scharfenberger L., Barnwell P. A. Protein binding and concentrations of cephaloridine and cefazolin in serum and interstitial fluid of dogs. J Infect Dis. 1976 Jun;133(6):642–647. doi: 10.1093/infdis/133.6.642. [DOI] [PubMed] [Google Scholar]
  53. Wilson D. E., Chalmers T. C., Madoff M. A. The passage of cephalothin into and out of ascitic fluid. Am J Med Sci. 1967 Apr;253(4):449–452. doi: 10.1097/00000441-196704000-00007. [DOI] [PubMed] [Google Scholar]
  54. Wise R., Gillett A. P., Cadge B., Durham S. R., Baker S. The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics. J Infect Dis. 1980 Jul;142(1):77–82. doi: 10.1093/infdis/142.1.77. [DOI] [PubMed] [Google Scholar]
  55. Wise R. Protein binding of beta-lactams: the effects on activity and pharmacology particularly tissue penetration. II. Studies in man. J Antimicrob Chemother. 1983 Aug;12(2):105–118. doi: 10.1093/jac/12.2.105. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES